Centralized Drug Screening Program

Description

Certiphi uses urine screening methodologies utilizing both laboratory and instant testing technologies. Tests will be performed through Certiphi’s vast pool of more than 8,000 collection sites located throughout the United States and Canada.

Once a participating program has offered you admission, Certiphi Screening will send you an email with instructions for completing the drug screen. This email will include a toll-free telephone number to contact with any questions regarding the process.

Individual programs may require you to submit to additional drug screenings following the initial screen.

Once a drug screen has been completed, Certiphi will provide the report to the student applicant as well as all programs offering acceptance.

Process

Upon your initial, conditional acceptance by a participating program, Certiphi Screening, Inc. sends an email to the preferred email address you entered in the PharmCAS application. This email provides you with access to a secure, online form via which you will provide basic identifying information, consent for this report to be procured, and payment of $53. Your consent will serve for all programs, and you will not be asked to provide consent upon receiving additional, conditional acceptance offers by participating programs.

Once you have provided payment, Certiphi will provide additional instructions on available drug screening collection facilities to be used for specimen collection. Upon report completion, Certiphi will send an email to your preferred email address notifying you that your drug screening report is complete. A copy of the report will also be provided immediately to the program(s).

Privacy

The report procured during this process will not be released to any party other than the programs requesting this report.

Upon testing by the laboratory, if the specimen is found to be positive for one or more of the drugs tested, you will receive a telephone call from a Medical Review Officer (MRO) at Certiphi Screening, Inc. The MRO will consult with you and your physician to obtain proof as to why the drug/medication was in your specimen.

If you do not return the call to the MRO within three business days, the report will be delivered as a “positive” drug screen.

Participating Programs

To see which PharmCAS schools use the Certiphi Screening Centralized Drug Screening Program, please refer to the Background Checks and Drug Screenings section of the PharmCAS School Directory. Not all programs conduct a drug screening through PharmCAS.